CVE:MJN Cronos Group (MJN) Stock Price, News & Analysis → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free MJN Stock Alerts C$12.15 -0.23 (-1.86%) (As of 03/2/2018) Add Compare Share Share Today's RangeC$11.90▼C$12.4750-Day RangeC$12.15▼C$12.1552-Week RangeC$1.58▼C$14.83Volume1.39 million shsAverage Volume2.07 million shsMarket CapitalizationC$1.73 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cronos Group alerts: Email Address Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Cronos Group Stock (CVE:MJN)Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.Read More MJN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MJN Stock News HeadlinesFebruary 29, 2024 | marketwatch.comCronos Group 4Q Loss Narrows as New Cannabis Markets Boost RevenueFebruary 28, 2024 | benzinga.comCronos Group's Earnings: A PreviewApril 27, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.November 27, 2023 | benzinga.comCronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facilitySeptember 5, 2023 | benzinga.comWhat's Going On With Cronos Group Shares?September 1, 2023 | markets.businessinsider.comCronos Group (CRON) Receives a Buy from Roth MKMAugust 31, 2023 | benzinga.comWhy Cronos Group Stock (CRON) Is SkyrocketingJuly 10, 2023 | msn.comCronos Group: Unlikely DealApril 27, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.July 6, 2023 | msn.comAltria-backed cannabis producer Cronos explores sale, sources sayJuly 6, 2023 | msn.comAltria-Backed Cannabis Producer Cronos Group Considers Sale, Stock Waivers Amid Takeover InterestJune 15, 2023 | marketwatch.comCronos Group Inc. stock remains steady Thursday, underperforms marketMay 31, 2023 | markets.businessinsider.comCronos To Exit U.S. CBD OperationsMay 31, 2023 | benzinga.comCronos Group Announces Streamlined Operating Structure to Improve Cash FlowMay 21, 2023 | benzinga.comCronos Group Stock (NASDAQ:CRON), Insider Trading ActivityApril 26, 2023 | marketwatch.comCronos Group Inc. stock falls Monday, underperforms marketMarch 1, 2023 | benzinga.comCronos Group's Return On Capital Employed OverviewFebruary 25, 2023 | benzinga.comCronos Group Stock (NASDAQ:CRON), Quotes and News SummaryDecember 14, 2022 | marketwatch.comCronos Group Inc. stock outperforms market despite losses on the dayNovember 7, 2022 | marketwatch.comCronos Group Shares Decline on 3Q MissesNovember 7, 2022 | benzinga.comWhy Cronos Group Shares Are Falling SharplyOctober 26, 2022 | marketwatch.comCronos Shares Fall 5.1% After Hours On SEC Charges for Alleged Accounting FraudOctober 25, 2022 | msn.comCronos Group, former exec agree to pay fines as part of settlement with OSCOctober 24, 2022 | benzinga.comWhat's Going On With Cronos Group Stock Falling During Monday's After-Hours SessionSeptember 21, 2022 | finance.yahoo.comCronos Group Inc. (CRON)August 9, 2022 | msn.comRecap: Cronos Group Q2 EarningsAugust 9, 2022 | markets.businessinsider.comWhy Cronos Stock Is Getting Hammered TodaySee More Headlines Receive MJN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryCannabis Current SymbolCVE:MJN CUSIPN/A CIKN/A Webthecronosgroup.com Phone+1-416-5040004FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares142,653,000Free FloatN/AMarket CapC$1.73 billion OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMichael Ryan GorensteinPresident, Chief Executive Officer, Vice Chairman of the Board, Corporate SecretaryWilliam Lawrence HilsonChief Financial OfficerJason AdlerDirectorRyan RoebuckDirectorJames RudykDirectorAlan Mark Friedman (Age 45)Independent Director Michael Howard KrestellIndependent DirectorMore ExecutivesKey CompetitorsCanniMed TherapeuticsTSE:CMEDParamount Resources TECTSE:TETSirius XM CanadaTSE:XSRCanyon Services GroupTSE:FRCSandvineTSE:SVCView All Competitors MJN Stock Analysis - Frequently Asked Questions How have MJN shares performed in 2024? Cronos Group's stock was trading at C$12.15 at the start of the year. Since then, MJN shares have increased by 0.0% and is now trading at C$12.15. View the best growth stocks for 2024 here. Is Cronos Group a good dividend stock? Cronos Group (CVE:MJN) pays an annual dividend of C$1.65 per share and currently has a dividend yield of 0.00%. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (WEED), Organigram (OGI), Aphria (APHA), IMV (IMV), Leaf Mobile (LEAF), CanniMed Therapeutics (CMED). How do I buy shares of Cronos Group? Shares of MJN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:MJN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
